Senti Biosciences Stock Investor Sentiment

SNTI Stock  USD 2.12  0.06  2.75%   
Under 62% of Senti Biosciences' investor base is looking to short. The analysis of the overall investor sentiment regarding Senti Biosciences suggests that many traders are alarmed. Senti Biosciences' investing sentiment shows overall attitude of investors towards Senti Biosciences.
  

Senti Biosciences Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Senti Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a year ago at news.google.com         
Senti Bio to Participate in Upcoming Investor Conferences - Yahoo Finance
Google News at Macroaxis
over a year ago at news.google.com         
AGC beefs up Colorado cell and gene therapy production facility - FiercePharma
Google News at Macroaxis
over a year ago at news.google.com         
FDA again slams Biocons troubled plant in Malaysia, citing 8 ... - FiercePharma
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Research Analysts Updated EPS Estimates for August 15th
news
over a year ago at news.google.com         
GeneFab debuts as manufacturer, acquires Senti Bios production ... - FiercePharma
Google News at Macroaxis
over a year ago at globenewswire.com         
Senti Bio Announces Second Quarter 2023 Results and Pipeline Updates
Macroaxis News: globenewswire.com
over a year ago at news.google.com         
Senti Bio Announces Closing of Transaction Leveraging its CMC ... - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Merck still eyeing MA and has plenty of firepower to execute it - FiercePharma
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Short Interest in Senti Biosciences, Inc. Grows By 24.9
news
over a year ago at thelincolnianonline.com         
Triatomic Management LP Grows Stake in Senti Biosciences, Inc.
news
over a year ago at benzinga.com         
Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Senti Biosciences, Incorp...
benzinga news
over a year ago at news.google.com         
Board Member at Senti Biosciences Granted Stock Options Worth ... - Best Stocks
Google News at Macroaxis
over a year ago at www.macroaxis.com         
Acquisition by Susan Berland of 62500 shares of Senti Biosciences subject to Rule 16b-3
Macroaxis News
over a year ago at thelincolnianonline.com         
Financial Review Senti Biosciences and Its Competitors
news
over a year ago at finance.yahoo.com         
Senti Bio Highlights Initial Gene Circuit Data From Collaborations at the American Society of Gene a...
Yahoo News
Far too much social signal, news, headlines, and media speculation about Senti Biosciences that are available to investors today. That information is available publicly through Senti media outlets and privately through word of mouth or via Senti internal channels. However, regardless of the origin, that massive amount of Senti data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Senti Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Senti Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Senti Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Senti Biosciences alpha.

Senti Biosciences Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Senti Biosciences Trading Up 5.2 percent - MarketBeat
08/29/2024
2
Acquisition by Rajangam Kanya of 327750 shares of Senti Biosciences subject to Rule 16b-3
09/18/2024
3
Acquisition by Farokhzad Omid of 62500 shares of Senti Biosciences at 0.31 subject to Rule 16b-3
09/27/2024
4
Acquisition by Forbes Christopher of 17464 shares of Senti Biosciences at 2.77 subject to Rule 16b-3
10/04/2024
5
Senti Bio Announces Third Quarter 2024 Results and Recent Pipeline and Corporate Highlights
11/14/2024
6
Senti Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
11/20/2024

Complementary Tools for Senti Stock analysis

When running Senti Biosciences' price analysis, check to measure Senti Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Senti Biosciences is operating at the current time. Most of Senti Biosciences' value examination focuses on studying past and present price action to predict the probability of Senti Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Senti Biosciences' price. Additionally, you may evaluate how the addition of Senti Biosciences to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance